← Leaderboards
Lei Wang
Henry Ford Health System
$4,580,286
Attributed
$4,580,286
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $643.5K · FY2012–23$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,580,286 · 4
By mechanism
R01$4,204,036 · 3
R56$376,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Gabriel Sosne$1,184,324
- William H Beierwaltes$4,591,657
- Zheng Gang Zhang$14,094,277
- Jieli Chen$7,266,447
- Nour-Eddine Rhaleb$4,498,249
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularAmericanAffectTherapeutic EffectMediatingComplications Of Diabetes MellitusNeuronsNeurologic DysfunctionsSchwann CellsSpinal GangliaDiabeticPeripheral Nervous System DiseasesDesignPeripheral NervesDiabetic MouseDisabilityNeurological OutcomeNervous System PhysiologyDiabetes MellitusBaseAxonNon-Insulin-Dependent Diabetes MellitusEffective TherapyDb/Db Mouse
Grant awards (13)
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2023 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2022 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2021 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2020 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$376,250
R56 · FY2018 · DK · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2016 · DK · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2015 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$320,469
R01 · FY2015 · NS · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2014 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$317,265
R01 · FY2014 · NS · contact PI
Thymosin Beta 4 Promotes Recovery of Peripheral Neuropathy in Diabetic Mice$322,988
R01 · FY2013 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$309,253
R01 · FY2013 · NS · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$320,469
R01 · FY2012 · NS · contact PI